Biotech Investing

Bone Therapeutics Reports Positive Efficacy Data for the ALLOB® Phase IIA Spinal Fusion Trial

Biotech Investing

Ocular Therapeutix™ Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP

Biotech Investing

Chugai's ACTEMRA/RoACTEMRA Receives Breakthrough Therapy Designation from FDA

Biotech Investing

Biotech Investing Basics

Biotech Investing

Another Acquisition for Allergan Makes Six Since August

Biotech Investing

FDA Grants Breakthrough Therapy Designation for Genentech’s Alecensa®

Biotech Investing

Chugai's Alecensa Receives Breakthrough Therapy Designation from FDA

Biotech Investing

Evotec to Invest in Carrick Therapeutics

Biotech Investing

Hemostemix Granted Two Additional Patents in the US and in Canada

Biotech Investing

Naturally Splendid Hires New Chief Financial Officer

Biotech Investing

Enanta Pharmaceuticals Announces New Data Presentations at the AASLD Liver Meeting

Biotech Investing

Allergan Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to Inflammatory Disorder Development Program

Biotech Investing

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES